Clinical Characterization of Patients With Primary Biliary Cirrhosis Treated With Seladelpar in the Real-life Setting

ConditionPrimary Bilary Cirrhosis (PBC)

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorUniversity of Leipzig

About this trial

The seladelpar registry will collect real-world data of patients with PBC diagnosis treated with seladelpar in the real-life scenario in Germany and Switzerland.

Eligibility criteria

Qualifiers

Age ≥ 18 years

Diagnosis of PBC according to EASL criteria

Treatment with seladelpar

Written informed consent

Disqualifiers

current or previous participation in a phase I to IV interventional clinical trial for seladelpar treatment of PBC

Pregnancy and breastfeeding

Trial design

Treatments tested in this trial

Not listed

Trial groups

100 Participants

are grouped into 1 trial group

Locations

Germany

Charité - Universitätsmedizin Berlin Med. Klinik für Gastroenterologie, Infektiologie und Rheumatologie (CBF)12200, Berlin Germany

DRK Kliniken Berlin Mitte Klinik für Innere Medizin - Gastroenterologie, Hepatologie, Diabetologie, Angiologie und Abhängigkeitserkrankungen13359, Berlin Germany

Universitätsklinikum Frankfurt Medizinische Klinik I, Haus 11/Gastroenterologie60590, Frankfurt Germany

Asklepios Klinik St. Georg, Leberzentrum, IFI-Institut20099, Hamburg Germany

Sponsors and collaborators

University of Leipzig

Lead sponsor

Source ClinicalTrials.gov